Affichage navigation
  • Contactez-nous
  • Service Clients: 01 71 16 55 99
  • Livraison à 0,01€ sur les livres
  • Paiement 100% sécurisé
FR (€)
Recherche avancée
FR (€)
Mon panier

Shop by Category

Voir tous les titres Biologie, Bactériologie, maladies infectieuses

Biomedicine & Pharmacotherapy

Format (l x h) : 210 x 280 mm | Editeur : ELSEVIER | Date de publication : 01/1956 | Périodicité : 10 n° par an | Langue(s) de publication : Anglais

An international multidisciplinary journal with two objectives :- to create an interface between clinical and laboratory responses to drugs and to investigate critical approaches to different pathologies with regard to biological and clinical data,- ...en savoir plus
An international multidisciplinary journal with two objectives :- to create an interface between clinical and laboratory responses to drugs and to investigate critical approaches to different pathologies with regard to biological and clinical data,- to provide a niche for authors whose work is not directly defined by the review criteria of existing journals. Biomedicine and pharmacotherapy is one of the few journals at the forefront of fundamental and technical science, biological and medical disciplines, therapeutics and pathological description. General fields of interest include molecular and cell biology, genetic disease, immunology and immunoregulation and chemotherapy. Special emphasis is placed on studies of specific topics such as differentiation, pharmacology and toxicology, preclinical and clinical pharmacology, the effects of drugs on cell structural and functional elements, the mechanism of gene regulation in normal and pathological cells, the role of viruses and parasites and the therapy of the diseases they induce. Brief reports of meetings, symposia and conferences will also be considered for publication as well as announcements of scientific meetings or academic courses.
Soyez le premier à commenter ce produit
  • 10 n° par an
  • Application iPhone/iPad
  • Début de l'abonnement : maximum 48h après réception du paiement.
Remise de 20%
main product photo
Ajouter à la liste d'achats
* Champs obligatoires

Choisissez chaque critère ci-dessus pour accéder à votre offre

découvrez nos offres
Revue - Numérique icon

Choisissez chaque critère ci-dessus pour accéder à votre offre

 
933,00 €
 
Revues
933,00 €
Ajouter au panier
Ajouter au panier
  • 10 n° par an
  • Application iPhone/iPad
  • Début de l'abonnement : maximum 48h après réception du paiement.

Détails

An international multidisciplinary journal with two objectives :- to create an interface between clinical and laboratory responses to drugs and to investigate critical approaches to different pathologies with regard to biological and clinical data,- to provide a niche for authors whose work is not directly defined by the review criteria of existing journals. Biomedicine and pharmacotherapy is one of the few journals at the forefront of fundamental and technical science, biological and medical disciplines, therapeutics and pathological description. General fields of interest include molecular and cell biology, genetic disease, immunology and immunoregulation and chemotherapy. Special emphasis is placed on studies of specific topics such as differentiation, pharmacology and toxicology, preclinical and clinical pharmacology, the effects of drugs on cell structural and functional elements, the mechanism of gene regulation in normal and pathological cells, the role of viruses and parasites and the therapy of the diseases they induce. Brief reports of meetings, symposia and conferences will also be considered for publication as well as announcements of scientific meetings or academic courses.
Plus d'infos
État du stock EN STOCK
Editeur ELSEVIER
Périodicité 10 n° par an
Format Revues
Rédigez votre propre commentaire
Seuls les utilisateurs munis d'un compte client peuvent laisser un commentaire. Veuillez vous connecter ou créer un compte s'il vous plait.

Copyright © 2023 Elsevier, à l'exception de certains contenus fournis par des tiers.

Ce site utilise des cookies. Pour refuser ou en savoir plus, consultez notre page Cookies.

RELX Group